Bouthillier A, De Montigny C
Department of Psychiatry, McGill University, Montréal, Québec, Canada.
Eur J Pharmacol. 1988 Jun 22;151(1):135-8. doi: 10.1016/0014-2999(88)90703-0.
Acute benzodiazepine administration has been reported to antagonize the effect of cholecystokinin both in the periphery and in the central nervous system. A two-week treatment with either diazepam (5 mg/kg per day) or flurazepam (15 mg/kg per day) markedly reduced the excitatory effect of microiontophoretically applied sulphated cholecystokinin octapeptide-(26-33) on rat CA3 hippocampal pyramidal neurons but not that of acetylcholine. In view of the sustained anxiolytic activity of benzodiazepines that contrasts with their transient sedative effect, the present results suggest that the reduction of neuronal responsiveness to cholecystokinin by these drugs might be related to their anxiolytic property.
